These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19760244)

  • 1. In vitro simultaneous transfer of lipids to HDL in coronary artery disease and in statin treatment.
    Lo Prete AC; Dina CH; Azevedo CH; Puk CG; Lopes NH; Hueb WA; Maranhão RC
    Lipids; 2009 Oct; 44(10):917-24. PubMed ID: 19760244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid transfer to high-density lipoproteins in coronary artery disease patients with and without previous cerebrovascular ischemic events.
    Barbosa CJDG; Maranhão RC; Barreiros RS; Freitas FR; Franci A; Strunz CMC; Arantes FBB; Tavoni TM; Ramires JAF; Kalil Filho R; Nicolau JC
    Clin Cardiol; 2019 Nov; 42(11):1100-1105. PubMed ID: 31489679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
    Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
    Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous transfer of cholesterol, triglycerides, and phospholipids to high-density lipoprotein in aging subjects with or without coronary artery disease.
    Azevedo CH; Wajngarten M; Prete AC; Diament J; Maranhão RC
    Clinics (Sao Paulo); 2011; 66(9):1543-8. PubMed ID: 22179156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).
    Klerkx AH; de Grooth GJ; Zwinderman AH; Jukema JW; Kuivenhoven JA; Kastelein JJ
    Eur J Clin Invest; 2004 Jan; 34(1):21-8. PubMed ID: 14984434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid parameters in patients with acute coronary syndromes versus stable coronary artery disease.
    Vonbank A; Saely CH; Rein P; Drexel H
    Eur J Clin Invest; 2015 Oct; 45(10):1092-7. PubMed ID: 26255620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDL
    Chaudhary R; Kinderytė M; Chaudhary R; Sukhi A; Bliden K; Tantry U; Gurbel P
    Cardiovasc Revasc Med; 2019 Nov; 20(11):1001-1006. PubMed ID: 30626544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid transfers to HDL are predictors of precocious clinical coronary heart disease.
    Maranhão RC; Freitas FR; Strunz CM; Santos RD; Mansur AJ; Mansur AP
    Clin Chim Acta; 2012 Feb; 413(3-4):502-5. PubMed ID: 22120728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esterification of HDL-cholesterol is Decreased in Diabetes Mellitus and CAD and Enhanced Following Treatment with Statins.
    Bagheri B; Alikhani A; Mokhtari H; Rasouli M
    Med Arch; 2018 Jun; 72(3):197-201. PubMed ID: 30061766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin prescription strategies and atherogenic cholesterol goals attainment in Lebanese coronary artery disease patients.
    Lama S; Souraya D; Youssef F
    Int J Clin Pharm; 2017 Aug; 39(4):919-926. PubMed ID: 28523462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of intensive lipid lowering on lipid profiles over time and tolerability in stable coronary artery disease: insights from a subanalysis of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
    Kawashiri MA; Yamagishi M; Sakamoto T; Takayama T; Hiro T; Daida H; Hirayama A; Saito S; Yamaguchi T; Matsuzaki M;
    Cardiovasc Ther; 2013 Dec; 31(6):335-43. PubMed ID: 23409830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF; Muhlestein JB; Horne BD; Hart NI; Bair TL; Molhuizen HO; Anderson JL
    Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosis.
    van Wijk JP; Buirma R; van Tol A; Halkes CJ; De Jaegere PP; Plokker HW; van der Helm YJ; Castro Cabezas M
    Atherosclerosis; 2005 Jan; 178(1):147-55. PubMed ID: 15585212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ratio of Eicosapentaenoic Acid (EPA) to Arachidonic Acid may be a Residual Risk Marker in Stable Coronary Artery Disease Patients Receiving Treatment with Statin Following EPA Therapy.
    Tani S; Nagao K; Kawauchi K; Yagi T; Atsumi W; Matsuo R; Hirayama A
    Am J Cardiovasc Drugs; 2017 Oct; 17(5):409-420. PubMed ID: 28634822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein lipase HindIII polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease.
    Javorský M; Gasperíková D; Ukropec J; Sedláková B; Riecanský I; Krizanová O; Seböková E; Dobríková M; Klimes I; Tkác I
    Wien Klin Wochenschr; 2007; 119(15-16):476-82. PubMed ID: 17721767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease.
    Blankenberg S; Rupprecht HJ; Bickel C; Jiang XC; Poirier O; Lackner KJ; Meyer J; Cambien F; Tiret L;
    J Am Coll Cardiol; 2003 Jun; 41(11):1983-9. PubMed ID: 12798569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.